With respect to the total IgE level in the tears of AKC patients, we think that the observed decrease is attributable to the rebamipide eyedrops because 4–6 weeks after the start of their administration it was significantly reduced even in cases 2 and 4 that had been resistant to treatment with anti-allergy medication. This evidence concerns the gene IGHE and Allergy.